Pharmacists in Fishers, Indiana


61 Pharmacists found in Fishers
female pharmacist

Rihab Ahmed


Pharmacist
12812 Broncos Dr, Fishers, IN 46037
317-457-6136    

male pharmacist

Mr. Robert Pison, RPH


Pharmacist
13098 Publishers Dr, Fishers, IN 46038
317-598-4409    

female pharmacist

Samantha M. Schulman


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
7272 Fishers Crossing Dr, Fishers, IN 46038
317-579-0209    



male pharmacist

Mr. Sanjay Ashokkumar Joshi, RPH.


Pharmacist
11750 Commercial Dr, T-1350, Fishers, IN 46038
317-845-4962     317-845-4962

female pharmacist

Dr. Sarah Abigail Lowry, PHARM.D.



13121 Olio Rd, Fishers, IN 46037
317-355-1411    

male pharmacist

Scott Boas


Pharmacist
9799 E 116th St, Fishers, IN 46037
317-913-5505    

female pharmacist

Stacey Lynne Hart



11591 Olio Rd, Fishers, IN 46037
317-585-2702    

male pharmacist

Dr. Stephen A Masleid, RPH PHARMD


Pharmacist
13741 E 116th St, Fishers, IN 46037
317-595-8764     317-595-8831

female pharmacist

Sydney E Enyeart


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
9799 E 116th St, Fishers, IN 46037
317-913-5505    

female pharmacist

Taylor Haan, PHARMD


Pharmacist
11591 Olio Rd, Fishers, IN 46037
317-585-2702    

female pharmacist

Taylor Benner, PHARMD


Pharmacist
7272 Fishers Crossing Dr, Fishers, IN 46038
317-579-0209    

female pharmacist

Mrs. Theresa Ann Elias


Pharmacist
11750 Commercial Dr, T-1350, Fishers, IN 46038
317-845-4962    

female pharmacist

Tisa Kelley


Pharmacist
11588 Allisonville Rd, Fishers, IN 46038
317-842-7773    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.